Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Austin, Texas
- Most recent report
- 10-Q, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1160308
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 70
News 8 of 277
- 8-K Leadership change Jun 8, 2026
- 8-K Significant contract Mar 13, 2026
- 8-K Significant contract Jan 27, 2026
- 8-K Current report on a material event Jan 9, 2026
- 8-K Significant contract Oct 30, 2025
- 8-K Significant contract Oct 29, 2025
- 8-K Current report on a material event Sep 2, 2025
- 8-K Shareholder vote results Jun 6, 2025
Prospectuses and Registrations 8 of 99
- S-8 Registration statement for an employee plan Aug 11, 2026
- 424B5 Prospectus supplement for an offering Oct 30, 2025
- 424B5 Prospectus supplement for an offering Oct 29, 2025
- S-8 Registration statement for an employee plan Oct 1, 2024
- S-8 Registration statement for an employee plan Jul 26, 2024
- 424B5 Prospectus supplement for an offering Jun 28, 2024
- S-3 Shelf registration statement May 9, 2024
- S-8 Registration statement for an employee plan Mar 7, 2024
Proxies 8 of 39
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- PRE 14A Preliminary proxy statement Apr 10, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- PRE 14A Preliminary proxy statement Apr 12, 2024
Ownership 8 of 448
- 4 Insider reported a trade Jul 24, 2026
- 4 Insider reported a trade Jun 22, 2026
- 144 Notice of a proposed sale of restricted stock Jun 22, 2026
- 4 Insider reported a trade Mar 20, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- 4 Insider reported a trade Feb 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 13, 2026
Other 8 of 67
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- EFFECT Notice that a registration became effective May 21, 2024
- CORRESP Reply to SEC staff May 20, 2024
- UPLOAD Comment letter from SEC staff May 14, 2024
- ARS Annual report sent to shareholders Apr 26, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- EFFECT Notice that a registration became effective Jul 16, 2021
Everything here comes from Savara Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.